- Psilocybin, a psychedelic compound found in "magic mushrooms," can help aid in the treatment of alcohol use disorder along with therapy, according to a new study.
- Results, published in JAMA Psychiatry , found that those given two high doses of psilocybin in addition to psychotherapy had significantly fewer heavy drinking days over 32 weeks compared to those who received psychotherapy alone.
- The researchers concluded that the combination led to "robust and sustained decreases in drinking."
- Several companies are examining psilocybin for mental health disorders. Compass Pathways ( NASDAQ: CMPS ) is examining it as a treatment for treatment-resistant depression and anorexia .
- Cybin ( NYSE: CYBN ) has CYB003, a deuterated psilocybin analog, under investigation for alcohol use disorder and major depressive disorder.
- MindMed ( NASDAQ: MNMD ) has a study examining the acute effects of psilocybin.
- MindMed ( MNMD ) recently saw a surge after a young investor told a newspaper he built an activist stake in the company . The stock closed ~36% higher Thursday in reaction the to news, but closed flat the following day .
For further details see:
Magic mushrooms psychedelic compound can help with treatment of alcohol use disorder